Literature DB >> 28534144

Coordination of Care in Survivorship After Treatment of Hematological Malignancies-The Journey is Not Over Yet.

Catherine J Lee1, Lori S Muffly2.   

Abstract

The number of adult survivors of hematologic malignancies is steadily growing. This population is at moderate to high risk for cancer survivorship issues including physical and psychosocial sequelae of intensive cancer therapies. Although cancer survivorship is a growing field in pediatric and solid tumor oncology, survivorship care and research has often been overlooked in the hematologic malignancies. In this review, we focus specifically on survivorship issues related to adult patients with hematologic malignancies and provide commentary on the role of cancer survivorship, proposed survivorship care models, and the economic and health policy obstacles associated with moving the cancer survivorship field forward in this very important patient population.

Entities:  

Keywords:  Cancer survivorship; Hematologic malignancies; Therapy

Mesh:

Year:  2017        PMID: 28534144     DOI: 10.1007/s11899-017-0390-1

Source DB:  PubMed          Journal:  Curr Hematol Malig Rep        ISSN: 1558-8211            Impact factor:   3.952


  32 in total

1.  Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation: joint recommendations of the European Group for Blood and Marrow Transplantation, the Center for International Blood and Marrow Transplant Research, and the American Society of Blood and Marrow Transplantation.

Authors:  J Douglas Rizzo; John R Wingard; Andre Tichelli; Stephanie J Lee; Maria Teresa Van Lint; Linda J Burns; Stella M Davies; James L M Ferrara; Gérard Socié
Journal:  Biol Blood Marrow Transplant       Date:  2006-02       Impact factor: 5.742

Review 2.  Evaluation of effectiveness of survivorship programmes: how to measure success?

Authors:  Michael T Halpern; Keith E Argenbright
Journal:  Lancet Oncol       Date:  2017-01       Impact factor: 41.316

3.  Unmet needs of Australian and Canadian haematological cancer survivors: a cross-sectional international comparative study.

Authors:  Alix Hall; H Sharon Campbell; Rob Sanson-Fisher; Marita Lynagh; Catherine D'Este; Robin Burkhalter; Mariko Carey
Journal:  Psychooncology       Date:  2013-02-25       Impact factor: 3.894

Review 4.  Hodgkin lymphoma: Late effects of treatment and guidelines for surveillance.

Authors:  Andrea K Ng; Flora E van Leeuwen
Journal:  Semin Hematol       Date:  2016-05-12       Impact factor: 3.851

Review 5.  Risk-based health care, the cancer survivor, the oncologist, and the primary care physician.

Authors:  Mary S McCabe; Ann H Partridge; Eva Grunfeld; Melissa M Hudson
Journal:  Semin Oncol       Date:  2013-12       Impact factor: 4.929

Review 6.  Models of survivorship care provision in adult patients with haematological cancer: an integrative literature review.

Authors:  Karen Taylor; Raymond Javan Chan; Leanne Monterosso
Journal:  Support Care Cancer       Date:  2015-02-19       Impact factor: 3.603

7.  Trends in leukemia incidence and survival in the United States (1973-1998).

Authors:  Yang Xie; Stella M Davies; Ying Xiang; Leslie L Robison; Julie A Ross
Journal:  Cancer       Date:  2003-05-01       Impact factor: 6.860

8.  When the safety net of treatment has been removed: patients' unmet needs at the completion of treatment for haematological malignancies.

Authors:  E A Lobb; D Joske; P Butow; L J Kristjanson; P Cannell; G Cull; B Augustson
Journal:  Patient Educ Couns       Date:  2009-03-09

9.  Care Coordination/Home Telehealth: the systematic implementation of health informatics, home telehealth, and disease management to support the care of veteran patients with chronic conditions.

Authors:  Adam Darkins; Patricia Ryan; Rita Kobb; Linda Foster; Ellen Edmonson; Bonnie Wakefield; Anne E Lancaster
Journal:  Telemed J E Health       Date:  2008-12       Impact factor: 3.536

10.  ReCAP: ASCO Core Curriculum for Cancer Survivorship Education.

Authors:  Charles L Shapiro; Paul B Jacobsen; Tara Henderson; Arti Hurria; Larissa Nekhlyudov; Andrea Ng; Antonella Surbone; Deborah K Mayer; Julia H Rowland; Charles L Shapiro; Paul B Jacobsen; Tara Henderson; Arti Hurria; Larissa Nekhlyudov; Andrea Ng; Antonella Surbone; Deborah K Mayer; Julia H Rowland
Journal:  J Oncol Pract       Date:  2016-01-26       Impact factor: 3.840

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.